Oral Vaccines Market Research Report 2025 | Oral Immunization, Edible Vaccines, Mucosal Vaccine Analysis, Pediatric & Adult Oral Vaccine Trends, Global Oral Vaccine Industry Forecast

The global Oral Vaccines market size was valued at USD 2545.6 million in 2022 and is forecast to a readjusted size of USD 3375.9 million by 2029 with a CAGR of 4.1% during review period.

Introduction: The Rise of Oral Vaccines in Global Health

The oral vaccines market is poised for significant growth by 2025, as global healthcare challenges and demand for accessible, cost-effective immunization methods continue to rise. Oral vaccines, which are administered via ingestion instead of injections, offer unique advantages such as ease of use, higher patient compliance, and better distribution, especially in resource-constrained regions. With advances in biotechnology and the need for more scalable health solutions, the market for oral vaccines is expected to transform the landscape of global immunization efforts.

Oral vaccines are revolutionizing the immunization process by providing a simpler, non-invasive alternative to traditional injectable vaccines. These vaccines are often preferred for their ease of administration, especially in areas where trained medical professionals and healthcare infrastructure are limited. As the world faces a growing burden of infectious diseases, the need for innovative vaccine delivery methods is more critical than ever. Oral vaccines hold the potential to address this challenge, improving global vaccination coverage and contributing to the fight against diseases like rotavirus, cholera, and polio.

In addition to their accessibility, oral vaccines offer an attractive solution for enhancing patient compliance. Unlike injections, which can cause discomfort or fear, oral vaccines can be taken with minimal resistance, promoting greater adherence to vaccination schedules, especially in pediatric populations.

Market Drivers: Key Forces Behind the Oral Vaccines Market Growth

• Several factors are driving the oral vaccines market growth, creating opportunities for both established players and emerging innovators. The increasing demand for global immunization solutions is one of the primary factors fueling market expansion. Diseases like rotavirus, typhoid, and hepatitis still pose significant threats, particularly in low- and middle-income countries. Oral vaccines offer a more cost-effective, easily transportable, and stable alternative to injectable vaccines, making them an attractive option for mass immunization campaigns.
• Another major driver is the increasing focus on emerging infectious diseases and the global push for faster vaccine development. The COVID-19 pandemic demonstrated the urgent need for scalable vaccine distribution, and oral vaccines, being easier to distribute and administer, are positioned to play an essential role in future pandemic preparedness. Additionally, cost reduction in vaccine delivery, through reduced cold chain requirements and fewer healthcare personnel, is fueling widespread adoption.

Innovation: Technological Breakthroughs in Oral Vaccine Development

• Innovation within the oral vaccines market is transforming the way vaccines are developed and delivered. Recombinant oral vaccines are one of the most promising innovations. By using genetically engineered organisms to produce antigens, these vaccines can be more effective, safer, and easier to produce than traditional vaccines. Additionally, advancements in nanotechnology are enhancing the stability, absorption, and effectiveness of oral vaccines. Nanoparticles are being designed to protect vaccines as they pass through the digestive tract, ensuring better immune response activation.
• The development of combination vaccines is another area of innovation driving the market. Combination vaccines allow for the simultaneous delivery of multiple vaccines in a single dose, simplifying vaccination schedules, reducing the number of visits, and boosting coverage rates. This is particularly beneficial in regions with limited healthcare resources, as it reduces the need for multiple appointments and logistical challenges.

Regional Market Dynamics: A Global Perspective

• The growth of the oral vaccines market is influenced by regional variations in healthcare needs, infrastructure, and disease burden. In North America and Europe, while the focus has traditionally been on injectable vaccines, there is growing interest in oral vaccines, particularly for diseases such as influenza and travel-related illnesses. These regions are also at the forefront of vaccine innovation and the development of oral vaccine technologies for emerging diseases.
• In Asia-Pacific, which has a high prevalence of infectious diseases, oral vaccines are in increasing demand. Countries like India, China, and Indonesia are focusing on improving immunization coverage for diseases such as hepatitis A, rotavirus, and cholera. The large populations and the challenges in reaching remote or underserved areas drive the adoption of oral vaccines in these regions. Moreover, with a growing emphasis on healthcare modernization, these regions are investing in new technologies that facilitate the development and distribution of oral vaccines.
• In Latin America and Africa, the demand for oral vaccines is particularly strong due to the high burden of preventable diseases and the need for scalable vaccination solutions. Polio eradication efforts in Africa have relied heavily on the oral polio vaccine, and similar strategies are being employed to combat other infectious diseases. The ability of oral vaccines to bypass the need for cold chain storage and highly trained personnel makes them an ideal solution in these regions, where healthcare access can be limited.

Strategic Considerations: Path to Success in the Oral Vaccines Market

• For companies looking to capitalize on the oral vaccines market, a few key strategic considerations are essential. Regulatory compliance is a primary concern, as vaccines must meet rigorous safety and efficacy standards set by health authorities such as the FDA and WHO. Companies must ensure that their oral vaccines meet these standards to gain approval for global distribution.
• Partnerships with governments, NGOs, and international health organizations will be crucial to expanding market reach and improving access to oral vaccines in underserved regions. Such collaborations can support large-scale immunization campaigns and facilitate the distribution of oral vaccines to areas where they are most needed.
• Furthermore, market education and addressing vaccine hesitancy are key components in driving adoption. With the rise of misinformation surrounding vaccines, it is important for companies to educate both healthcare professionals and the public about the benefits of oral vaccines. Building trust in the safety and efficacy of oral vaccines will be critical for ensuring their widespread use.

Conclusion: Oral Vaccines Market 2025 - A Future of Accessible Immunization

The oral vaccines market is positioned for remarkable growth by 2025, driven by technological advancements, innovation in vaccine delivery, and the increasing demand for scalable immunization solutions. Oral vaccines offer distinct advantages, particularly in regions with limited healthcare infrastructure, providing an opportunity to address a wide range of infectious diseases with greater efficiency.

With continued innovations in nanotechnology, combination vaccines, and recombinant technologies, oral vaccines will play an increasingly important role in global health initiatives. The success of the market will depend on strategic collaborations, regulatory approvals, and public trust in the safety and efficacy of these vaccines. As the world continues to face emerging health threats, oral vaccines represent a key component in achieving universal immunization coverage and improving global health outcomes.

NOTE:

Quants and Trends is proud to offer an extensive portfolio of meticulously researched healthcare market reports, numbering in the thousands. We also provide tailored customization services to ensure our insights align precisely with your strategic objectives and informational needs. For personalized assistance or to discuss your specific requirements, we invite you to get in touch with our team. We also encourage you to request a complimentary sample PDF report. Please visit our Sample Request Page to receive yours today.

   Merck
   GSK
   Sanofi
   Lanzhou Institute
   Serum Institute
   Valneva
   Shanghai United Cell
   Bibcol
   PaxVax
   Vabiotech
   Tiantan Biological
   EuBiologics
   Panacea Biotec Ltd
   Bio-Med
   Halfkin Bio-Pharmaceuticals

   Rotavirus Vaccine
   Cholera Vaccine
   Oral Polio Vaccine

   Public
   Private

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Oral Vaccines Market in 2025?

Oral vaccines offer easy administration, increasing patient compliance. Their ability to be stored at room temperature also makes them more accessible, especially in resource-limited regions. Additionally, oral vaccines can stimulate both mucosal and systemic immunity, making them effective for preventing various diseases.

What are the weaknesses of the Oral Vaccines Market in 2025?

One challenge is the limited number of diseases that oral vaccines can effectively target compared to injectable vaccines. There’s also a need for advanced delivery systems to ensure the stability of the vaccine in the stomach, and some vaccines might face issues in maintaining consistent immune responses.

What opportunities exist for the Oral Vaccines Market in 2025?

The increasing demand for non-invasive vaccination methods opens up opportunities for oral vaccines. Advancements in biotechnology and improved formulation technologies are making oral vaccines more viable for a broader range of diseases. Additionally, growing healthcare access in emerging markets presents a significant opportunity for oral vaccine adoption.

What are the threats to the Oral Vaccines Market in 2025?

The oral vaccines market faces competition from injectable vaccines, which remain the standard for many diseases due to their proven effectiveness. Regulatory hurdles and the challenge of ensuring long-term stability and efficacy could limit the growth of oral vaccines. Furthermore, public hesitancy around new vaccine technologies could impact acceptance.

What are the political factors affecting the Oral Vaccines Market in 2025?

Government policies on healthcare and vaccine distribution will play a key role in the growth of oral vaccines. Political stability and the prioritization of immunization programs can encourage investments and regulatory support. However, changing policies in different regions might create barriers or delays in market adoption.

How do economic factors influence the Oral Vaccines Market in 2025?

Economic factors such as healthcare spending, affordability of vaccines, and the economic stability of countries directly impact the market. In emerging economies, the cost-effectiveness of oral vaccines may drive adoption, while in developed economies, the financial capability to support advanced vaccine technologies is crucial for sustained growth.

What social factors are important for the Oral Vaccines Market in 2025?

Public perception of oral vaccines and overall vaccine acceptance are critical. Societal trends favoring less invasive treatments and the growing awareness of the benefits of vaccination can lead to increased demand. However, vaccine hesitancy and misinformation may hinder public confidence and uptake.

What technological factors affect the Oral Vaccines Market in 2025?

Advances in biotechnology, vaccine delivery systems, and stabilization techniques are essential for the success of oral vaccines. Technology plays a major role in enhancing the effectiveness and shelf-life of oral vaccines, as well as improving their ease of administration and transportation.

What environmental factors should be considered in the Oral Vaccines Market in 2025?

The environmental impact of vaccine production, including waste management and energy consumption, is gaining attention. Additionally, the ability of oral vaccines to be stored at room temperature makes them more environmentally friendly compared to vaccines requiring cold chain storage.

What legal factors influence the Oral Vaccines Market in 2025?

Legal regulations surrounding vaccine approval, safety standards, and intellectual property rights are crucial. The process of obtaining regulatory approval for new oral vaccines is often lengthy and complex. Legal frameworks also impact how vaccines are distributed, marketed, and used globally.

Who are the suppliers in the Oral Vaccines Market in 2025?

Suppliers include raw material providers for vaccine production, such as pharmaceutical companies, biotech firms, and research institutions. They supply the active ingredients, adjuvants, and excipients needed for the formulation of oral vaccines.

What are the inputs required for the Oral Vaccines Market in 2025?

Inputs include research and development data, vaccine formulation technologies, manufacturing equipment, regulatory approval processes, and clinical trial data. Additionally, funding, raw materials, and skilled labor are essential to producing and distributing oral vaccines.

What are the processes involved in the Oral Vaccines Market in 2025?

The processes involve vaccine research and development, formulation optimization, clinical trials, regulatory approvals, manufacturing, packaging, distribution, and market launch. Post-launch, continuous monitoring and improvement of vaccine efficacy and safety are also part of the processes.

Who are the customers in the Oral Vaccines Market in 2025?

Customers include healthcare providers, government agencies, international organizations, and end-users (patients). Additionally, pharmaceutical distributors and health ministries in emerging and developed markets are key buyers of oral vaccines.

What are the outputs of the Oral Vaccines Market in 2025?

The outputs are the oral vaccines themselves, which are delivered to healthcare systems worldwide. These vaccines aim to prevent diseases, improve public health, and reduce healthcare costs associated with preventable illnesses. Additionally, scientific knowledge and advancements in vaccine technologies are outcomes of this market.

What is the threat of new entrants in the Oral Vaccines Market in 2025?

The threat of new entrants is moderate. Developing oral vaccines requires significant investment in R&D, technology, and regulatory approval. Established players with strong portfolios and experience dominate the market, creating high barriers to entry. However, advances in biotechnology may reduce these barriers over time.

What is the bargaining power of suppliers in the Oral Vaccines Market in 2025?

The bargaining power of suppliers is moderate to high. Suppliers of raw materials, such as active ingredients and excipients, have some leverage due to the specialized nature of these materials. However, competition among suppliers and the increasing availability of alternative raw materials may limit their power.

What is the bargaining power of buyers in the Oral Vaccines Market in 2025?

The bargaining power of buyers is moderate. Governments and large healthcare organizations often hold substantial purchasing power due to their volume requirements, especially in emerging markets. However, individual patients have limited bargaining power, as oral vaccines are typically distributed through healthcare systems and government programs.

What is the threat of substitute products in the Oral Vaccines Market in 2025?

The threat of substitutes is high. Injectable vaccines, which are well-established and proven to be effective, continue to be the primary alternative to oral vaccines. In addition, emerging vaccine technologies like nasal or transdermal vaccines could further increase competition in the market.

What is the level of competitive rivalry in the Oral Vaccines Market in 2025?

The level of competitive rivalry is moderate to high. Established pharmaceutical companies and biotechnology firms are actively investing in the development of oral vaccines. While the market is still evolving, competition is expected to intensify as new technologies emerge, and companies aim to capture market share in the growing demand for non-invasive vaccination options.

What are the key raw materials required for the Oral Vaccines Market in 2025?

The key raw materials include active pharmaceutical ingredients (APIs), adjuvants, excipients, and stabilizers that ensure the vaccine's efficacy and stability. Additionally, packaging materials and specialized equipment for the manufacturing process are essential.

What are the sources of raw materials for oral vaccine production?

Raw materials are primarily sourced from pharmaceutical suppliers, biotechnology companies, and chemical manufacturers. These suppliers provide the ingredients needed for the vaccine formulation, including specialized proteins, viruses, or genetic materials, and the necessary compounds to enhance immune response.

What role do research and development play in the upstream activities of oral vaccine production?

R&D plays a crucial role in the upstream activities by focusing on the development of new formulations, enhancing vaccine delivery methods, and ensuring stability in the oral vaccine. Innovative technologies and improvements in production processes also rely heavily on continuous research and development.

How do regulatory requirements affect upstream activities in the Oral Vaccines Market in 2025?

Regulatory requirements significantly impact upstream activities as vaccine manufacturers must comply with stringent guidelines for raw material sourcing, production, and testing. These regulations ensure that vaccines are safe, effective, and manufactured under good manufacturing practices (GMP), influencing the supply chain and production timeline.

What challenges are faced in upstream activities for the Oral Vaccines Market in 2025?

Challenges include the complexity of formulating stable oral vaccines, securing high-quality raw materials, and managing the long and expensive approval processes. Additionally, supply chain disruptions, fluctuations in raw material costs, and regulatory hurdles can delay production and increase costs.

What are the key processes in the midstream activities of the Oral Vaccines Market in 2025?

Key processes include vaccine manufacturing, formulation, quality control, and clinical testing. Midstream activities focus on ensuring that the oral vaccines meet safety, efficacy, and regulatory standards before they are ready for distribution.

How does quality control affect the midstream activities in oral vaccine production?

Quality control is critical in ensuring that the oral vaccines meet required specifications for potency, stability, and safety. Stringent testing is done throughout the manufacturing process to identify and mitigate any issues that could affect vaccine quality or effectiveness.

What role do contract manufacturers play in the midstream activities?

Contract manufacturers are often engaged in the production of oral vaccines, especially for large-scale manufacturing. They play a vital role in scaling production, maintaining consistency, and meeting the demand for vaccines, while also adhering to regulatory requirements and GMP guidelines.

How do distribution channels influence midstream activities in the Oral Vaccines Market?

Distribution channels are essential in the midstream process, as they determine how vaccines are transported from manufacturers to healthcare providers. Efficient logistics, cold chain management (where necessary), and regulatory compliance in different regions are key factors in ensuring vaccines reach the right markets on time.

What are the challenges faced in the midstream activities of oral vaccine production?

Challenges include ensuring efficient production scaling, maintaining vaccine stability during transport, and meeting the demand in a timely manner. Additionally, regulatory compliance across various countries, managing supply chain disruptions, and maintaining cost-effectiveness in manufacturing pose ongoing challenges in the midstream activities.

What are the key activities in the downstream stage of the Oral Vaccines Market in 2025?

Key activities in the downstream stage include vaccine distribution to healthcare providers, administration to patients, and post-vaccination monitoring. It also involves marketing efforts to educate healthcare professionals and the public about the benefits and safety of oral vaccines.

How does healthcare infrastructure impact downstream activities in the Oral Vaccines Market?

Healthcare infrastructure plays a crucial role in ensuring that oral vaccines reach the intended populations. Well-established distribution networks, healthcare facilities, and trained personnel are essential for effective vaccine delivery and administration, particularly in underserved regions.

What role does patient acceptance play in the downstream activities of oral vaccines?

Patient acceptance is critical to the success of oral vaccines. Educating the public on the safety, efficacy, and benefits of oral vaccines can help increase adoption. Social factors, such as trust in vaccination programs and awareness campaigns, also influence patient willingness to receive the vaccine.

What are the challenges in the downstream stage of the Oral Vaccines Market?

Challenges include ensuring equitable distribution, particularly in rural and remote areas, maintaining vaccine efficacy during transportation, and overcoming vaccine hesitancy. Additionally, there may be challenges in achieving widespread public trust and engagement in new vaccine technologies.

How do pricing strategies affect the downstream activities in the Oral Vaccines Market?

Pricing strategies are vital to ensuring accessibility and affordability of oral vaccines. Competitive pricing, along with support from government or non-governmental organizations, can facilitate wider adoption. However, pricing must balance affordability with the need for sustained investment in production and distribution.

Chapter 1, to describe Oral Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Vaccines, with price, sales, revenue and global market share of Oral Vaccines from 2018 to 2023.
Chapter 3, the Oral Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Vaccines.
Chapter 14 and 15, to describe Oral Vaccines sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Oral Vaccines
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Oral Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Rotavirus Vaccine
       1.3.3 Cholera Vaccine
       1.3.4 Oral Polio Vaccine
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Oral Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Public
       1.4.3 Private
   1.5 Global Oral Vaccines Market Size & Forecast
       1.5.1 Global Oral Vaccines Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Oral Vaccines Sales Quantity (2018-2029)
       1.5.3 Global Oral Vaccines Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Merck
       2.1.1 Merck Details
       2.1.2 Merck Major Business
       2.1.3 Merck Oral Vaccines Product and Services
       2.1.4 Merck Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Merck Recent Developments/Updates
   2.2 GSK
       2.2.1 GSK Details
       2.2.2 GSK Major Business
       2.2.3 GSK Oral Vaccines Product and Services
       2.2.4 GSK Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 GSK Recent Developments/Updates
   2.3 Sanofi
       2.3.1 Sanofi Details
       2.3.2 Sanofi Major Business
       2.3.3 Sanofi Oral Vaccines Product and Services
       2.3.4 Sanofi Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Sanofi Recent Developments/Updates
   2.4 Lanzhou Institute
       2.4.1 Lanzhou Institute Details
       2.4.2 Lanzhou Institute Major Business
       2.4.3 Lanzhou Institute Oral Vaccines Product and Services
       2.4.4 Lanzhou Institute Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Lanzhou Institute Recent Developments/Updates
   2.5 Serum Institute
       2.5.1 Serum Institute Details
       2.5.2 Serum Institute Major Business
       2.5.3 Serum Institute Oral Vaccines Product and Services
       2.5.4 Serum Institute Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Serum Institute Recent Developments/Updates
   2.6 Valneva
       2.6.1 Valneva Details
       2.6.2 Valneva Major Business
       2.6.3 Valneva Oral Vaccines Product and Services
       2.6.4 Valneva Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Valneva Recent Developments/Updates
   2.7 Shanghai United Cell
       2.7.1 Shanghai United Cell Details
       2.7.2 Shanghai United Cell Major Business
       2.7.3 Shanghai United Cell Oral Vaccines Product and Services
       2.7.4 Shanghai United Cell Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Shanghai United Cell Recent Developments/Updates
   2.8 Bibcol
       2.8.1 Bibcol Details
       2.8.2 Bibcol Major Business
       2.8.3 Bibcol Oral Vaccines Product and Services
       2.8.4 Bibcol Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Bibcol Recent Developments/Updates
   2.9 PaxVax
       2.9.1 PaxVax Details
       2.9.2 PaxVax Major Business
       2.9.3 PaxVax Oral Vaccines Product and Services
       2.9.4 PaxVax Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 PaxVax Recent Developments/Updates
   2.10 Vabiotech
       2.10.1 Vabiotech Details
       2.10.2 Vabiotech Major Business
       2.10.3 Vabiotech Oral Vaccines Product and Services
       2.10.4 Vabiotech Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Vabiotech Recent Developments/Updates
   2.11 Tiantan Biological
       2.11.1 Tiantan Biological Details
       2.11.2 Tiantan Biological Major Business
       2.11.3 Tiantan Biological Oral Vaccines Product and Services
       2.11.4 Tiantan Biological Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Tiantan Biological Recent Developments/Updates
   2.12 EuBiologics
       2.12.1 EuBiologics Details
       2.12.2 EuBiologics Major Business
       2.12.3 EuBiologics Oral Vaccines Product and Services
       2.12.4 EuBiologics Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 EuBiologics Recent Developments/Updates
   2.13 Panacea Biotec Ltd
       2.13.1 Panacea Biotec Ltd Details
       2.13.2 Panacea Biotec Ltd Major Business
       2.13.3 Panacea Biotec Ltd Oral Vaccines Product and Services
       2.13.4 Panacea Biotec Ltd Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 Panacea Biotec Ltd Recent Developments/Updates
   2.14 Bio-Med
       2.14.1 Bio-Med Details
       2.14.2 Bio-Med Major Business
       2.14.3 Bio-Med Oral Vaccines Product and Services
       2.14.4 Bio-Med Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.14.5 Bio-Med Recent Developments/Updates
   2.15 Halfkin Bio-Pharmaceuticals
       2.15.1 Halfkin Bio-Pharmaceuticals Details
       2.15.2 Halfkin Bio-Pharmaceuticals Major Business
       2.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
       2.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Oral Vaccines by Manufacturer

   3.1 Global Oral Vaccines Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Oral Vaccines Revenue by Manufacturer (2018-2023)
   3.3 Global Oral Vaccines Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Oral Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Oral Vaccines Manufacturer Market Share in 2022
       3.4.2 Top 6 Oral Vaccines Manufacturer Market Share in 2022
   3.5 Oral Vaccines Market: Overall Company Footprint Analysis
       3.5.1 Oral Vaccines Market: Region Footprint
       3.5.2 Oral Vaccines Market: Company Product Type Footprint
       3.5.3 Oral Vaccines Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Oral Vaccines Market Size by Region
       4.1.1 Global Oral Vaccines Sales Quantity by Region (2018-2029)
       4.1.2 Global Oral Vaccines Consumption Value by Region (2018-2029)
       4.1.3 Global Oral Vaccines Average Price by Region (2018-2029)
   4.2 North America Oral Vaccines Consumption Value (2018-2029)
   4.3 Europe Oral Vaccines Consumption Value (2018-2029)
   4.4 Asia-Pacific Oral Vaccines Consumption Value (2018-2029)
   4.5 South America Oral Vaccines Consumption Value (2018-2029)
   4.6 Middle East and Africa Oral Vaccines Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Oral Vaccines Sales Quantity by Type (2018-2029)
   5.2 Global Oral Vaccines Consumption Value by Type (2018-2029)
   5.3 Global Oral Vaccines Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Oral Vaccines Sales Quantity by Application (2018-2029)
   6.2 Global Oral Vaccines Consumption Value by Application (2018-2029)
   6.3 Global Oral Vaccines Average Price by Application (2018-2029)

7 North America

   7.1 North America Oral Vaccines Sales Quantity by Type (2018-2029)
   7.2 North America Oral Vaccines Sales Quantity by Application (2018-2029)
   7.3 North America Oral Vaccines Market Size by Country
       7.3.1 North America Oral Vaccines Sales Quantity by Country (2018-2029)
       7.3.2 North America Oral Vaccines Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Oral Vaccines Sales Quantity by Type (2018-2029)
   8.2 Europe Oral Vaccines Sales Quantity by Application (2018-2029)
   8.3 Europe Oral Vaccines Market Size by Country
       8.3.1 Europe Oral Vaccines Sales Quantity by Country (2018-2029)
       8.3.2 Europe Oral Vaccines Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Oral Vaccines Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Oral Vaccines Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Oral Vaccines Market Size by Region
       9.3.1 Asia-Pacific Oral Vaccines Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Oral Vaccines Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Oral Vaccines Sales Quantity by Type (2018-2029)
   10.2 South America Oral Vaccines Sales Quantity by Application (2018-2029)
   10.3 South America Oral Vaccines Market Size by Country
       10.3.1 South America Oral Vaccines Sales Quantity by Country (2018-2029)
       10.3.2 South America Oral Vaccines Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Oral Vaccines Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Oral Vaccines Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Oral Vaccines Market Size by Country
       11.3.1 Middle East & Africa Oral Vaccines Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Oral Vaccines Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Oral Vaccines Market Drivers
   12.2 Oral Vaccines Market Restraints
   12.3 Oral Vaccines Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Oral Vaccines and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Oral Vaccines
   13.3 Oral Vaccines Production Process
   13.4 Oral Vaccines Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Oral Vaccines Typical Distributors
   14.3 Oral Vaccines Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Oral Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Oral Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Merck Basic Information, Manufacturing Base and Competitors
   Table 4. Merck Major Business
   Table 5. Merck Oral Vaccines Product and Services
   Table 6. Merck Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Merck Recent Developments/Updates
   Table 8. GSK Basic Information, Manufacturing Base and Competitors
   Table 9. GSK Major Business
   Table 10. GSK Oral Vaccines Product and Services
   Table 11. GSK Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. GSK Recent Developments/Updates
   Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
   Table 14. Sanofi Major Business
   Table 15. Sanofi Oral Vaccines Product and Services
   Table 16. Sanofi Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Sanofi Recent Developments/Updates
   Table 18. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
   Table 19. Lanzhou Institute Major Business
   Table 20. Lanzhou Institute Oral Vaccines Product and Services
   Table 21. Lanzhou Institute Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Lanzhou Institute Recent Developments/Updates
   Table 23. Serum Institute Basic Information, Manufacturing Base and Competitors
   Table 24. Serum Institute Major Business
   Table 25. Serum Institute Oral Vaccines Product and Services
   Table 26. Serum Institute Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Serum Institute Recent Developments/Updates
   Table 28. Valneva Basic Information, Manufacturing Base and Competitors
   Table 29. Valneva Major Business
   Table 30. Valneva Oral Vaccines Product and Services
   Table 31. Valneva Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Valneva Recent Developments/Updates
   Table 33. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
   Table 34. Shanghai United Cell Major Business
   Table 35. Shanghai United Cell Oral Vaccines Product and Services
   Table 36. Shanghai United Cell Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. Shanghai United Cell Recent Developments/Updates
   Table 38. Bibcol Basic Information, Manufacturing Base and Competitors
   Table 39. Bibcol Major Business
   Table 40. Bibcol Oral Vaccines Product and Services
   Table 41. Bibcol Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Bibcol Recent Developments/Updates
   Table 43. PaxVax Basic Information, Manufacturing Base and Competitors
   Table 44. PaxVax Major Business
   Table 45. PaxVax Oral Vaccines Product and Services
   Table 46. PaxVax Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. PaxVax Recent Developments/Updates
   Table 48. Vabiotech Basic Information, Manufacturing Base and Competitors
   Table 49. Vabiotech Major Business
   Table 50. Vabiotech Oral Vaccines Product and Services
   Table 51. Vabiotech Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. Vabiotech Recent Developments/Updates
   Table 53. Tiantan Biological Basic Information, Manufacturing Base and Competitors
   Table 54. Tiantan Biological Major Business
   Table 55. Tiantan Biological Oral Vaccines Product and Services
   Table 56. Tiantan Biological Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. Tiantan Biological Recent Developments/Updates
   Table 58. EuBiologics Basic Information, Manufacturing Base and Competitors
   Table 59. EuBiologics Major Business
   Table 60. EuBiologics Oral Vaccines Product and Services
   Table 61. EuBiologics Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 62. EuBiologics Recent Developments/Updates
   Table 63. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
   Table 64. Panacea Biotec Ltd Major Business
   Table 65. Panacea Biotec Ltd Oral Vaccines Product and Services
   Table 66. Panacea Biotec Ltd Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 67. Panacea Biotec Ltd Recent Developments/Updates
   Table 68. Bio-Med Basic Information, Manufacturing Base and Competitors
   Table 69. Bio-Med Major Business
   Table 70. Bio-Med Oral Vaccines Product and Services
   Table 71. Bio-Med Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 72. Bio-Med Recent Developments/Updates
   Table 73. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
   Table 74. Halfkin Bio-Pharmaceuticals Major Business
   Table 75. Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
   Table 76. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 77. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
   Table 78. Global Oral Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 79. Global Oral Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 80. Global Oral Vaccines Average Price by Manufacturer (2018-2023) & (USD/Unit)
   Table 81. Market Position of Manufacturers in Oral Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 82. Head Office and Oral Vaccines Production Site of Key Manufacturer
   Table 83. Oral Vaccines Market: Company Product Type Footprint
   Table 84. Oral Vaccines Market: Company Product Application Footprint
   Table 85. Oral Vaccines New Market Entrants and Barriers to Market Entry
   Table 86. Oral Vaccines Mergers, Acquisition, Agreements, and Collaborations
   Table 87. Global Oral Vaccines Sales Quantity by Region (2018-2023) & (K Units)
   Table 88. Global Oral Vaccines Sales Quantity by Region (2024-2029) & (K Units)
   Table 89. Global Oral Vaccines Consumption Value by Region (2018-2023) & (USD Million)
   Table 90. Global Oral Vaccines Consumption Value by Region (2024-2029) & (USD Million)
   Table 91. Global Oral Vaccines Average Price by Region (2018-2023) & (USD/Unit)
   Table 92. Global Oral Vaccines Average Price by Region (2024-2029) & (USD/Unit)
   Table 93. Global Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 94. Global Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 95. Global Oral Vaccines Consumption Value by Type (2018-2023) & (USD Million)
   Table 96. Global Oral Vaccines Consumption Value by Type (2024-2029) & (USD Million)
   Table 97. Global Oral Vaccines Average Price by Type (2018-2023) & (USD/Unit)
   Table 98. Global Oral Vaccines Average Price by Type (2024-2029) & (USD/Unit)
   Table 99. Global Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 100. Global Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 101. Global Oral Vaccines Consumption Value by Application (2018-2023) & (USD Million)
   Table 102. Global Oral Vaccines Consumption Value by Application (2024-2029) & (USD Million)
   Table 103. Global Oral Vaccines Average Price by Application (2018-2023) & (USD/Unit)
   Table 104. Global Oral Vaccines Average Price by Application (2024-2029) & (USD/Unit)
   Table 105. North America Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 106. North America Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 107. North America Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 108. North America Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 109. North America Oral Vaccines Sales Quantity by Country (2018-2023) & (K Units)
   Table 110. North America Oral Vaccines Sales Quantity by Country (2024-2029) & (K Units)
   Table 111. North America Oral Vaccines Consumption Value by Country (2018-2023) & (USD Million)
   Table 112. North America Oral Vaccines Consumption Value by Country (2024-2029) & (USD Million)
   Table 113. Europe Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 114. Europe Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 115. Europe Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 116. Europe Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 117. Europe Oral Vaccines Sales Quantity by Country (2018-2023) & (K Units)
   Table 118. Europe Oral Vaccines Sales Quantity by Country (2024-2029) & (K Units)
   Table 119. Europe Oral Vaccines Consumption Value by Country (2018-2023) & (USD Million)
   Table 120. Europe Oral Vaccines Consumption Value by Country (2024-2029) & (USD Million)
   Table 121. Asia-Pacific Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 122. Asia-Pacific Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 123. Asia-Pacific Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 124. Asia-Pacific Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 125. Asia-Pacific Oral Vaccines Sales Quantity by Region (2018-2023) & (K Units)
   Table 126. Asia-Pacific Oral Vaccines Sales Quantity by Region (2024-2029) & (K Units)
   Table 127. Asia-Pacific Oral Vaccines Consumption Value by Region (2018-2023) & (USD Million)
   Table 128. Asia-Pacific Oral Vaccines Consumption Value by Region (2024-2029) & (USD Million)
   Table 129. South America Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 130. South America Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 131. South America Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 132. South America Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 133. South America Oral Vaccines Sales Quantity by Country (2018-2023) & (K Units)
   Table 134. South America Oral Vaccines Sales Quantity by Country (2024-2029) & (K Units)
   Table 135. South America Oral Vaccines Consumption Value by Country (2018-2023) & (USD Million)
   Table 136. South America Oral Vaccines Consumption Value by Country (2024-2029) & (USD Million)
   Table 137. Middle East & Africa Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 138. Middle East & Africa Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 139. Middle East & Africa Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 140. Middle East & Africa Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 141. Middle East & Africa Oral Vaccines Sales Quantity by Region (2018-2023) & (K Units)
   Table 142. Middle East & Africa Oral Vaccines Sales Quantity by Region (2024-2029) & (K Units)
   Table 143. Middle East & Africa Oral Vaccines Consumption Value by Region (2018-2023) & (USD Million)
   Table 144. Middle East & Africa Oral Vaccines Consumption Value by Region (2024-2029) & (USD Million)
   Table 145. Oral Vaccines Raw Material
   Table 146. Key Manufacturers of Oral Vaccines Raw Materials
   Table 147. Oral Vaccines Typical Distributors
   Table 148. Oral Vaccines Typical Customers

List of Figures

   Figure 1. Oral Vaccines Picture
   Figure 2. Global Oral Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Oral Vaccines Consumption Value Market Share by Type in 2022
   Figure 4. Rotavirus Vaccine Examples
   Figure 5. Cholera Vaccine Examples
   Figure 6. Oral Polio Vaccine Examples
   Figure 7. Global Oral Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 8. Global Oral Vaccines Consumption Value Market Share by Application in 2022
   Figure 9. Public Examples
   Figure 10. Private Examples
   Figure 11. Global Oral Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 12. Global Oral Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 13. Global Oral Vaccines Sales Quantity (2018-2029) & (K Units)
   Figure 14. Global Oral Vaccines Average Price (2018-2029) & (USD/Unit)
   Figure 15. Global Oral Vaccines Sales Quantity Market Share by Manufacturer in 2022
   Figure 16. Global Oral Vaccines Consumption Value Market Share by Manufacturer in 2022
   Figure 17. Producer Shipments of Oral Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 18. Top 3 Oral Vaccines Manufacturer (Consumption Value) Market Share in 2022
   Figure 19. Top 6 Oral Vaccines Manufacturer (Consumption Value) Market Share in 2022
   Figure 20. Global Oral Vaccines Sales Quantity Market Share by Region (2018-2029)
   Figure 21. Global Oral Vaccines Consumption Value Market Share by Region (2018-2029)
   Figure 22. North America Oral Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 23. Europe Oral Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 24. Asia-Pacific Oral Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 25. South America Oral Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 26. Middle East & Africa Oral Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 27. Global Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 28. Global Oral Vaccines Consumption Value Market Share by Type (2018-2029)
   Figure 29. Global Oral Vaccines Average Price by Type (2018-2029) & (USD/Unit)
   Figure 30. Global Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 31. Global Oral Vaccines Consumption Value Market Share by Application (2018-2029)
   Figure 32. Global Oral Vaccines Average Price by Application (2018-2029) & (USD/Unit)
   Figure 33. North America Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 34. North America Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 35. North America Oral Vaccines Sales Quantity Market Share by Country (2018-2029)
   Figure 36. North America Oral Vaccines Consumption Value Market Share by Country (2018-2029)
   Figure 37. United States Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 38. Canada Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Mexico Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Europe Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 41. Europe Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 42. Europe Oral Vaccines Sales Quantity Market Share by Country (2018-2029)
   Figure 43. Europe Oral Vaccines Consumption Value Market Share by Country (2018-2029)
   Figure 44. Germany Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 45. France Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. United Kingdom Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. Russia Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Italy Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Asia-Pacific Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 50. Asia-Pacific Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 51. Asia-Pacific Oral Vaccines Sales Quantity Market Share by Region (2018-2029)
   Figure 52. Asia-Pacific Oral Vaccines Consumption Value Market Share by Region (2018-2029)
   Figure 53. China Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 54. Japan Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. Korea Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. India Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Southeast Asia Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Australia Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. South America Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 60. South America Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 61. South America Oral Vaccines Sales Quantity Market Share by Country (2018-2029)
   Figure 62. South America Oral Vaccines Consumption Value Market Share by Country (2018-2029)
   Figure 63. Brazil Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 64. Argentina Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 65. Middle East & Africa Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 66. Middle East & Africa Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 67. Middle East & Africa Oral Vaccines Sales Quantity Market Share by Region (2018-2029)
   Figure 68. Middle East & Africa Oral Vaccines Consumption Value Market Share by Region (2018-2029)
   Figure 69. Turkey Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 70. Egypt Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. Saudi Arabia Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. South Africa Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. Oral Vaccines Market Drivers
   Figure 74. Oral Vaccines Market Restraints
   Figure 75. Oral Vaccines Market Trends
   Figure 76. Porters Five Forces Analysis
   Figure 77. Manufacturing Cost Structure Analysis of Oral Vaccines in 2022
   Figure 78. Manufacturing Process Analysis of Oral Vaccines
   Figure 79. Oral Vaccines Industrial Chain
   Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 81. Direct Channel Pros & Cons
   Figure 82. Indirect Channel Pros & Cons
   Figure 83. Methodology
   Figure 84. Research Process and Data Source